CVC Fund VI closes acquisition of Theramex
CVC Capital Partners (CVC) has closed CVC Fund VI’s acquisition of the international women’s health assets which the fund agreed to acquire from Teva Pharmaceutical Industries Ltd in Q3 2017. The new company, called Theramex, is a global specialty pharmaceutical company dedicated to women and their health. Headquartered in London, UK,

